Log In
BCIQ
Print this Print this
 

KAF156

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionImidazolopiperazine derivative
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/15/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today